WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 1'4701 Infant (under 12 months) mortality rate: 382
GDP / capita (US$): 2'9701 Child (under 5 years) mortality rate: 532

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 193  188  183  178  173  139  117  95 
Births
Surviving infants
Pop. less than 5 years 31  31  30  29  29  22  20  19 
Pop. less than 15 years 80  78  76  74  72  61  56  45 
Female 15-49 years 48  46  45  44  43  33  24  19 

Number of reported case

(Click for retrospective incidence data for Sao Tome and Principe)
Diphtheria
Japanese encephalitis
Measles 10  519 
Mumps
Pertussis
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total) 12 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Sao Tome and Principe)
Vaccine year result method % card seen                                                
BCG 2007  96  DHS   93  97  99  99  99  99  81  100 
DTP1 2007  94  DHS   93  100  98  98  98  90 
DTP3 2007  87  DHS   93  97  96  96  98  98  82  92 
HepB_BD         
HepB3 2006  94  EPI   97  97  96  96  98  98 
Hib3          97  96  96  98 
JapEnc         
MCV 2007  84  DHS   93  91  92  91  93  90  69  71 
MCV2         
PCV1          99  64 
PCV3          97 
Pol3 2007  87  DHS   93  97  96  96  98  99  87  90 
Rota1         
Rota_last         
Rubella1         
TT2plus 2006  95  EPI   97  90  92  90  87  90  75  65 
PAB         
VAD1          78  91  90  80  80 
YFV 2006  86  EPI   97  91  92  91  93  90 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Sao Tome and Principe)
BCG 97  99  99  99  99  81  99 
DTP1 99  98  98  98  99  89  97 
DTP3 97  96  96  98  98  82  92 
HepB3 97  96  96  98  98 
HepB_BD
Hib3 97  96  96  98 
MCV 91  92  91  92  90  69  71 
MCV2
PCV3 97 
Pol3 97  96  96  98  99  87  90 
Rota_last
YFV 92  93  92  93  91 

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HepB birth; Yes
Measles 9, 17 months; Yes
OPV birth; 6, 10, 14 weeks; 17 months; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Td 1st contact; +1, +6 months; +1, +2 years; Yes
VitaminA 6, 12, 18, 24, 30,36 months; Yes and postpartum
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012-2016  2012-2016  2012-2016  2008-2012  2008-2012  2008-2012  2003/2007 
Nº of districts with microplans that include activities to raise immunization coverage number

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  Yes  No       

System performance

Total Nº districts in country number
Nº districts with DTP3 coverage >=80% number
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  100  100  14 
Nº districts with measles (MCV1) coverage >=95% number  
% of districts with MCV1 coverage >=95% From 0 to 100% 29  43  29  71   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  No  No       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  No  Yes  Yes  No  No 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 15  25  46  50 

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.